Skip to main content
. 2011 Mar;90(3):304–310. doi: 10.1177/0022034510389179

Table 1.

Characteristics of the Studies Included in the Systematic Review of the Effects of Oxalates on Dentin Hypersensitivity

Design Country Setting N of Observations by Group Age (yrs) Experimental Intervention Pain Stimuli
Pamir et al., 2007 RCT Turkey University 15 / 15 18–57 3% monohydrogen-monopotassium oxalate gel Thermal, evaporative
Gillam et al., 2004 RCT, split-mouth United Kingdom University 13 / 13 Mean 46.2 6.8% ferric oxalate Thermal, tactile, evaporative
Pillon et al., 2004 RCT, split-mouth Brazil University 15 / 15 NR 3% monohydrogen-monopotassium oxalate gel Routine activities of eating, drinking, and tooth cleaning
Camps and Pashley, 2003 RCT, split-mouth France University 87 / 87 17–52 3% monohydrogen-monopotassium oxalate gel Tactile, evaporative
Pereira et al., 2001 RCT, split-mouth Brazil University 23 / 21 / 24 / 14 21–45 3% monohydrogen-monopotassium oxalate gel, pH 2.5 and pH 4change/6% monohydrogen-monopotassium oxalate gel Tactile, evaporative
Morris et al., 1999 RCT, split-mouth United States Military 10 / 10 21–43 Oxalate-containing pre-polymerized resin solution Tactile, evaporative
Gillam et al., 1997 RCT, split-mouth United Kingdom University 11 / 33 Mean 45.1 3% monohydrogen-monopotassium oxalate Thermal, tactile, evaporative
Holborow, 1994 RCT, split-mouth New Zealand NR 30 / 30 NR 3% monohydrogen-monopotassium oxalate Thermal, tactile
Cuenin et al., 1991 RCT United States Military 6 / 7 29–68 3% monohydrogen-monopotassium oxalate Evaporative
Cooley and Sandoval, 1989 RCT, split-mouth United States University 28 / 28 NR 30% dipotassium oxalate + 3% monohydrogen-monopotassium oxalate Thermal
Muzzin and Johnson, 1989 RCT, split-mouth United States University 17 / 17 / 17 / 17 23–68 30% dipotassium oxalatechange/3% monohydrogen-monopotassium oxalatechange/30% dipotassium oxalate + 3% monohydrogen-monopotassium oxalate Thermal
Hansson, 1987 RCT United States University 14 / 14 23–63 30% dipotassium oxalate + 3% monohydrogen-monopotassium oxalate Thermal, routine stimuli

RCT, randomized controlled trial; NR, not reported.